Review draft · not published · copy pending client approval

Peptide analytical testing · San Diego

Built for peptide synthesis. Not adapted from somewhere else.

Identity, purity, content and safety for peptide injectables, from a sterile injectable manufacturing site in San Diego.

Research-use-only peptide companies 503A compounding pharmacies San Diego, California

What we do

We test peptide injectable products and issue a certificate of analysis against your specification.

The panels are built around what a peptide actually needs: the solvents your synthesis really uses, the elements a parenteral really has to clear, and identity confirmed by mass rather than by retention time alone.

HPLC stack with a sample vial
HPLC · Identity and purity

Built for peptides

A testing panel is only as good as its analyte list.

Three places where a general-purpose panel falls short of what a peptide injectable needs.

01 · Residual solventsUSP <467>
Schematic: general-purpose panels screen for hydrocarbon gases, the peptide-relevant panel screens for the solvents peptide synthesis uses ADAPTED PANEL hydrocarbon gases no role in solid-phase synthesis DMF not tested PEPTIDE-RELEVANT PANEL · USP <467> N,N-Dimethylformamide880 ppm N-Methylpyrrolidone530 ppm Acetonitrile410 ppm Diethyl ether / MTBE5000 ppm Dimethyl sulfoxide5000 ppm Piperidine · Trifluoroacetic acidin-house CLASS 1 AND CLASS 2 ANALYTES THAT CAN PLAUSIBLY BE PRESENT, PLUS THE ONES THAT DOMINATE PEPTIDE MANUFACTURE
02 · Elemental impuritiesICH Q3D · USP <233>
Schematic: the seven ICH Q3D Class 1 and Class 2A elements, nickel highlighted as the one most often missing ICH Q3D · PARENTERAL · ICP-MS, USP <233> CLASS 1 Cdcadmium · 2 Pblead · 5 Asarsenic · 15 Hgmercury · 3 CLASS 2A Cocobalt · 5 Vvanadium · 10 Ninickel · 20 most often missingplausible leachable fromstainless-steel contact LIMITS IN µg PER DAY · CLASS 3 AVAILABLE ON REQUEST
03 · IdentityLC-MS
Schematic: two co-eluting peaks look identical by retention time and separate by mass on LC-MS HPLC-UV · RETENTION TIME ? Product and a deletion analogue co-elute: one peak, one answer. LC-MS · MASS observed analogue theoretical mass Observed against theoretical: both values on the certificate. SCHEMATIC · NOT MEASURED DATA

01 · Solvents

The residual solvents that peptide synthesis actually leaves behind

Panels adapted from other industries screen for hydrocarbon gases that have no role in solid-phase peptide synthesis, and leave out the solvents that do. Our peptide-relevant panel covers the USP <467> Class 1 and Class 2 analytes that can plausibly be present, and adds the ones that dominate peptide manufacture and purification.

DMF is a Class 2 solvent, a reproductive toxicant, and the residual most likely to be present in an Fmoc-synthesised peptide. If your current panel does not include it, it is not testing your process.

02 · Elements

A five-element screen does not meet ICH Q3D for injection

For a parenteral product, ICH Q3D requires Class 1 and Class 2A as a minimum. Our standard panel covers all seven by ICP-MS, USP <233>.

Nickel is the one most often missing and the one worth having — a plausible leachable from stainless-steel process contact, with a low parenteral limit and a known sensitisation risk. Class 3 elements are available on request.

03 · Identity

Identity confirmed by mass

A retention time tells you a peak elutes where your standard elutes. It does not distinguish your peptide from a deletion or substitution analogue that co-elutes with it, and in solid-phase synthesis the most common impurities are the ones that look most like the product.

We confirm identity by LC-MS against the theoretical mass of your sequence and report both values on the certificate, so the identity claim is evidenced rather than asserted.

The full panels, tables and limits are on the service page.

See the tables

What we test

Three packages, one certificate

Every package is priced per lot and issued as a certificate of analysis against your specification. Tell us your product and batch size and we will scope it.

  • Appearance and cake examination
  • Identity by HPLC-UV against reference standard
  • Chromatographic purity, chromatogram issued
  • Assay and content per active, reported as mg per vial
  • Solubility and reconstitution
  • Water content by Karl Fischer, USP <921>
  • pH of reconstituted solution, USP <791>

Everything in Verify, run across multiple vials for conformity, plus:

  • Appearance and cake examination
  • Identity by HPLC-UV against reference standard
  • Chromatographic purity, chromatogram issued
  • Assay and content per active, reported as mg per vial
  • Solubility and reconstitution
  • Water content by Karl Fischer, USP <921>
  • pH of reconstituted solution, USP <791>
  • Identity confirmation by LC-MS, observed against theoretical mass
  • Visible particulates, USP <790>
  • Bacterial endotoxins by LAL, USP <85>, against your calculated dose limit
  • Sterility, USP <71>
  • Container closure integrity by dye ingress, USP <1207.1>

Everything in Release, plus:

  • Appearance and cake examination
  • Identity by HPLC-UV against reference standard
  • Chromatographic purity, chromatogram issued
  • Assay and content per active, reported as mg per vial
  • Solubility and reconstitution
  • Water content by Karl Fischer, USP <921>
  • pH of reconstituted solution, USP <791>
  • Identity confirmation by LC-MS, observed against theoretical mass
  • Visible particulates, USP <790>
  • Bacterial endotoxins by LAL, USP <85>, against your calculated dose limit
  • Sterility, USP <71>
  • Container closure integrity by dye ingress, USP <1207.1>
  • Residual solvents, peptide-relevant panel, USP <467>
  • Trifluoroacetic acid by ion chromatography
  • Elemental impurities, full ICH Q3D parenteral panel by ICP-MS
  • Method verification per USP <1226>, QA-reviewed certificate, deviation and OOS handling, retained samples held two years, audit-ready raw data
Added at this tierCarried from the tier below
Request a quote

Individual tests are available on their own or alongside a package. Ask us for the full test list.

Quality & compliance

The inspection record, up front.

Quality systems aligned with FDA, DEA, and international health authority requirements, maintained across three decades of U.S. manufacturing in San Diego.

30+

years of U.S. manufacturing

24,400sq ft

of cGMP space

Client sponsored audits welcomed by appointment. About the laboratory →

Jan 2023

FDA inspection

Most recent inspection passed.

DEA

DEA registered

Manufacturer: Schedule IV and V. Analytical lab: Schedule IV and V. On-site vaults.

In-house

cGMP QC & analytical labs

Chromatography, spectroscopy, dissolution, particle-size, TOC, DSC/TGA — method development through release testing.

Karl Fischer titrator
Karl Fischer · Water content
GC-MS system
GC-MS · Residual solvents
LC-MS system
LC-MS · Identity by mass

Working with us

How to submit

Vial counts depend on the package and on your batch size. Tell us your batch size and we will scale the plan to it.

Sample requirements and reference standards
  1. 01

    Request a quote

    Tell us your product, batch size and what you need tested. We send a submission form and a quotation.

  2. 02

    Ship the samples

    Send vials in original sealed containers, marked with lot number, product name, label strength and storage condition. Cold chain ships with a temperature monitor.

  3. 03

    Receive your certificate

    Results are reported against your specification, or against ours if you do not have one, and the certificate states the basis.

Resource

Peptide compounding status

Where each substance currently stands with FDA, and what that means for a 503A pharmacy or a product developer.

Last reviewed

Read the status page

Request a quote

Tell us what you are making and what you need on the certificate.

We will scope it and send a quotation.

Email
info@tppcdmo.com
Phone
858-623-1520
Laboratory
6828 Nancy Ridge Drive #100
San Diego, CA 92121
Submit
Tell us your product, batch size and what you need tested. We send a submission form and a quotation.